Management of headache and headache medications, 2nd edition
نویسندگان
چکیده
منابع مشابه
[The International Classification of Headache Disorders: 2nd edition].
The universally accepted international classification of headache disorders, first published in 1988, has now been replaced by a second edition ICDH-2. It is important to implement the new edition immediately since there are many important changes compared with the first edition. Application of the new edition is the only way to assure that the same diagnostic approach and appropriate treatment...
متن کاملHeadache medications and bone health.
Bones are dynamic, living tissues that undergo a process of remodeling throughout the lifespan. The skeleton continues to strengthen after birth until bone mass peaks in the teens or early 20s. Bone remodeling depends on 2 types of cells: osteoblasts (which lay down new bone) and osteoclasts (which cause bone resorption or thinning). Bone density tends to run in the family so the bone health of...
متن کاملNeurophysiological tests and neuroimaging procedures in non-acute headache (2nd edition).
BACKGROUND AND PURPOSE A large number of instrumental investigations are used in patients with non-acute headache in both research and clinical fields. Although the literature has shown that most of these tools contributed greatly to increasing understanding of the pathogenesis of primary headache, they are of little or no value in the clinical setting. METHODS This paper provides an update o...
متن کاملThe International Classification of Headache Disorders, 2nd edition: application to practice.
The International Classification of Headache Disorders, second edition (ICHD-II) was the result of 4 years' work by a large number of headache experts from different parts of the world. This article summarizes the main new features of ICHD-II, compared with the original International Headache Society classification: better definition of migraine with aura, inclusion of chronic migraine, inclusi...
متن کاملHeadache assessment and management.
THE LIFETIME PREVALENCE OF headache is more than 90%. In recent population-based surveys of US adults, nearly 25% annually report recurrent episodes of severe headache and 4% daily or neardaily headache. Prescription or nonprescription products are used by 9% of US adults each week to treat headache, matching hypertension as the primary reason for medication use. The majority of patients presen...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Neurology, Neurosurgery & Psychiatry
سال: 2001
ISSN: 0022-3050
DOI: 10.1136/jnnp.71.1.136d